Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00403390 · ClinicalTrials.gov registry record · NA
Generic vs. Name-Brand Levothyroxine
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT00403390 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 34 participants.
The verdict
NCT00403390, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
This study compares two different brands of thyroxine (thyroid hormone). Currently, pharmacists may be substituting generic formulations of thyroid hormone without your doctor knowing about this. Although a small difference in thyroid function is not significant in most healthy children, adolescents and adults, in infants and toddlers even a small difference in thyroid function can have important harmful consequences on brain development. The purpose of the present study is to learn whether the difference between brands of thyroid hormone that are currently being substituted is sufficient to cause a difference in thyroid function.
Interventions
- DRUG Brand Name Levothyroxine (Synthroid)
- DRUG Generic formulation of Levothyroxine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2006-11 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00403390
The ClinicalTrials.gov registry entry for NCT00403390 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Brand Name Levothyroxine (Synthroid) is the first listed.
NCT00403390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00403390 about?
NCT00403390 is a clinical study titled "Generic vs. Name-Brand Levothyroxine". This study compares two different brands of thyroxine (thyroid hormone). Currently, pharmacists may be substituting generic formulations of thyroid hormone without your doctor knowing about this. Although a small difference in thyroid function is not significant in most healthy children, adolescents...
What is the current status of trial NCT00403390?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2006-11. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00403390?
The interventions under investigation include: Brand Name Levothyroxine (Synthroid) (DRUG), Generic formulation of Levothyroxine (DRUG).
Who is sponsoring clinical trial NCT00403390?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.